About Avicenna Biosciences
Avicenna Biosciences is a private company based in Durham, North Carolina. It has reported $17,570,650 raised in five offerings on Form D since September 2020.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 1, 2024 | Jul 16, 2024 | $6,000,000fully sold | 1 | $6.0M | DebtRule 506(b) | Form D ↗ |
| Nov 3, 2023 | Feb 23, 2024 | $6,000,000of $10.0M target | 1 | $6.0M | DebtRule 506(b) | Form D ↗ |
| Apr 15, 2022 | Dec 30, 2022 | $3,000,000of $6.0M target | 1 | $3.0M | EquityRule 506(b) | Form D ↗ |
| Feb 17, 2022 | Oct 27, 2022amended Oct 30, 2025 | $70,650fully sold | 1 | $70,650 | Options, Securities on exerciseRule 506(b) | Form D/A ↗2 earlier filings |
| Aug 28, 2020 | Sep 14, 2020 | $2,500,000fully sold | 1 | $2.5M | EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $17,570,650 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Avicenna Biosciences's Form D filed Jul 16, 2024.
PB
Pieter Burger
Executive officer and director
JH
John Hamer
Director
DL
Dennis Langer
Director
TK
Thomas Kaiser
Executive officer and director
CM
Christopher Meldrum
President and director